Single-use Bioprocessing Market by Product (Single-use media bags and containers, Single-use assemblies, Single-use bioreactors, Disposable Mixers, and Other Products), Application (Filtration, Storage, Cell Culture, Mixing, and Purification), End User (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes): Global Market Size Estimates and Forecast (2022-2030)
The market crossed US$ 9.50 billion mark in 2022 and is expected to hit US$ 42.14 billion by 2030, recording a CAGR of 20.51% during the forecast period.
Single-use bioprocess market has been significantly growing with increasing demand for biopharmaceuticals.
Globally, there is an increasing ageing population who are prone to more chronic diseases & conditions. According to the UN Ageing population Report, 2020, about 727 million people was aged 65 years and older. This is expected to double by 2050 and reach 1.5 billion aged population. Thus, with the growing ageing population and associated chronic diseases and conditions, the demand for single-use bioprocessing systems is also increasing. As single-use bioprocessing systems increase the process efficiency and decrease the complicated process such as cleaning, sterilization, and maintenance of steel-based bioreactor systems. Thus, the increasing demand for biopharmaceuticals is driving the growth of single-use bioprocessing market. The single-use media bags and containers segment is boosting the market growth due to benefits such as lower capital investment and operating expenses, lower environmental footprint which helps boost the growth of single-use bioprocessing market.
Within the report, the market is segmented into product, application, end user, and geography. By product, the market is further segmented into single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and other products. Based on application, the market is segmented into filtration, storage, cell culture, mixing, and purification. By end user, the market is categorized into biopharmaceutical & pharmaceutical companies, CROs & CMOs, and academic & research institutes. Geographically, the market is subsegmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
Increasing demand for vaccine and biologics production empowers the growth of single use bioprocessing market.
The rising private investments and growing presence of favorable government are boosting the vaccine and biologics production by key players. For instance, in the Asia Pacific region, China followed by India has the high market potential for single-use bioprocessing systems. Further growing geriatric population and presence of skilled workforce in Asian countries promotes the growth of single-use bioprocessing market. For instance, Thermo Fisher Scientific expanded its bioprocessing capabilities with an investment of US$ 600 million due to increasing demands for vaccine and biologics production.
Growing geriatric population in North America accelerate the market growth.
The increasing demand for biopharmaceuticals and advantages of single-use bioprocessing is due to growing geriatric population in North America. The advantages such as high energy efficiency, low water usage, less floor space requirement, less installation cost, reduced cross-contamination, and fast implementation which promotes the growth of single-use bioprocessing market. According to the Population Reference Bureau, the geriatric population in the US was 52 million in 2018 and it is expected to reach 95 million in 2060 which is rise from 16% to 23%.
Recent strategic developments in single-use bioprocessing market
The single-use bioprocessing market has undergone several significant developments, and a few of these have been mentioned below:
- In March 2020, Biopharma business of General Electric Company’s Life Science division called Cytiva was acquired by Danaher. It is standalone operating company with Danaher’s Life Sciences segment.
- In September 2020, Thermo Fisher Scientific expanded its biologics development and manufacturing, cell and gene therapy capabilities, and drug product development capabilities at St. Louis site with an investment of more than USD 475 million.
The single-use bioprocessing market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Sartorius Stedim Biotech; Thermo Fisher Scientific; Danaher Corporation; Merck KGaA; Getinge AB; Eppendorf AG; Corning; Avantor; PBS Biotech, Inc; and G&G Technologies are among the prominent players operating in the market.
Target audience for the report:
- Biopharmaceutical companies
- Pharmaceutical companies
- Contract Research Organizations
- Contract Manufacturing Organizations
- Academic & Research Institutes
Scope of the report:
In this report, the market has been segmented based on:
- Product
- Single-use media bags and containers
- Single-use assemblies
- Single-use bioreactors
- Disposable Mixers
- Other Products
- Application
- Filtration
- Storage
- Cell culture
- Mixing
- Purification
- End User
- Biopharmaceutical & Pharmaceutical companies
- CROs & CMOs
- Academic & Research Institutes
- Region
- North America
- Europe
- Asia Pacific (APAC)
- South & Central America
- Middle East & Africa
- Companies profiled
- Sartorius Stedim Biotech
- Thermo Fisher Scientific
- Danaher Corporation
- Merck KGaA
- Getinge AB
- Eppendorf AG
- Corning
- Avantor
- PBS Biotech, Inc
- G&G Technologies
The List of Companies
- Sartorius Stedim Biotech
- Thermo Fisher Scientific
- Danaher Corporation
- Merck KGaA
- Getinge AB
- Eppendorf AG
- Corning
- Avantor
- PBS Biotech, Inc
- G&G Technologies